chr12-120660753-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001033677.2(CABP1):c.852T>A(p.Asp284Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,613,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001033677.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CABP1 | NM_001033677.2 | c.852T>A | p.Asp284Glu | missense_variant | 4/6 | ENST00000316803.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CABP1 | ENST00000316803.8 | c.852T>A | p.Asp284Glu | missense_variant | 4/6 | 1 | NM_001033677.2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152112Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251480Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135910
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461576Hom.: 0 Cov.: 30 AF XY: 0.0000330 AC XY: 24AN XY: 727102
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152112Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74290
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.852T>A (p.D284E) alteration is located in exon 4 (coding exon 4) of the CABP1 gene. This alteration results from a T to A substitution at nucleotide position 852, causing the aspartic acid (D) at amino acid position 284 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at